SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BoltAccesswire • 08/29/24
BOLT FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important September 3 Deadline in Securities Class Action – BOLTGlobeNewsWire • 08/28/24
The Schall Law Firm Urges Investors To Join A Lawsuit For Securities Fraud Against Bolt Biotherapeutics IncAccesswire • 08/28/24
Bronstein, Gewirtz and Grossman, LLC sends a Class Action Lawsuit reminder to shareholder investors for Bolt Biotherapeutics, Inc. to Lead the Class Action Lawsuit!Accesswire • 08/28/24
A Case Has Been Filed Against Bolt Biotherapeutics Inc For Securities Law Infractions And Stakeholders Are Encouraged To Contact The Schall Law FirmAccesswire • 08/27/24
A Shareholder alert for Bolt Biotherapeutics, Inc. was sent by Bronstein, Gewirtz and Grossman, LLC to Lead Class Action Lawsuit!Accesswire • 08/27/24
Shareholders With Losses In Bolt Biotherapeutics Inc Are Invited By The Schall Law Firm To Participate In A Securities Fraud LawsuitAccesswire • 08/26/24
BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Bolt Biotherapeutics, Inc. Shareholders to Contact the Firm!Accesswire • 08/26/24
A Case Is Being Pursued Against Bolt Biotherapeutics Inc For Securities Law Violations And The Schall Law Firm Urges Investors To Take PartAccesswire • 08/25/24
BOLT Announcement: Bronstein, Gewirtz and Grossman, LLC Announces Investor Securities Fraud Class Action Lawsuit Filed Against Bolt Biotherapeutics, Inc. and Chance to Actively ParticipateAccesswire • 08/25/24
A Securities Fraud Lawsuit Against Bolt Biotherapeutics Inc Has Been Filed And The Schall Law Firm Wants Investors To Reach OutAccesswire • 08/24/24
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLTGlobeNewsWire • 08/24/24
BOLT Investors Have Opportunity to lead Bolt Biotherapeutics, Inc. Securities Fraud LawsuitPRNewsWire • 08/23/24
The Schall Law Firm Is Suing Bolt Biotherapeutics, Inc. For Securities Law Violations And Stakeholders Are Urged To JoinAccesswire • 08/23/24
BOLT Announcement: Bronstein, Gewirtz and Grossman, LLC Announces Investor Securities Fraud Class Action Lawsuit Filed Against Bolt Biotherapeutics, Inc.Accesswire • 08/23/24
Bolt Biotherapeutics, Inc. Investors Are Invited By The Schall Law Firm To Lead A Securities Fraud CaseAccesswire • 08/22/24
BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 08/22/24
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important September 3 Deadline in Securities Class Action – BOLTGlobeNewsWire • 08/21/24
Shareholders With Losses In Bolt Biotherapeutics, Inc. Are Encouraged To Contact The Schall Law Firm About A Securities Fraud LawsuitAccesswire • 08/21/24
BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 08/21/24
The Schall Law Firm Encourages Bolt Biotherapeutics Inc Investors To Join A Securities Fraud Lawsuit Before Sep 3, 2024Accesswire • 08/20/24
Nationally Ranked Investors' Rights Firm Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders with Losses on their Investment in Bolt Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines- BOLTAccesswire • 08/20/24
The Schall Law Firm Invites Shareholders To Participate In Securities Fraud Lawsuit Against Bolt Biotherapeutics IncAccesswire • 08/19/24
BOLT Investors Have Opportunity to Lead Bolt Biotherapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz & Grossman, LLC Today!Accesswire • 08/19/24
The Schall Law Firm Encourages Investors To Join Securities Fraud Lawsuit Against Bolt Biotherapeutics IncAccesswire • 08/18/24
